| P50 | author | Chaker Aloui | Q57056429 |
| | Andreas Greinacher | Q64337422 |
| | Philippe Berthelot | Q71334694 |
| | Sofiane Tariket | Q86196161 |
| | Olivier Garraud | Q88918778 |
| | Fabrice Cognasse | Q89934483 |
| | Hind Hamzeh-Cognasse | Q91971791 |
| | Caroline Sut | Q120563486 |
| P2093 | author name string | Cécile Aubron | |
| | Sandrine Laradi | |
| P2860 | cites work | Streptococcus sanguinis-induced cytokine release from platelets. | Q54569157 |
| | Platelet granules: surprise packages | Q58413557 |
| | Platelet Activation, Inflammatory Mediators and Hypercholesterolemia | Q59536556 |
| | Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model | Q62977607 |
| | Analysis of the priming activity of lipids generated during routine storage of platelet concentrates | Q71042829 |
| | CD40-CD40L and platelet function: beyond hemostasis | Q73400879 |
| | Ultrastructural changes and activation differences in platelet concentrates stored in plasma and additive solution | Q74534404 |
| | Platelet-derived CD40L: the switch-hitting player of cardiovascular disease | Q74627856 |
| | Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates | Q74683780 |
| | The influence of platelet additive solutions on cytokine levels and complement activation in platelet concentrates during storage | Q78833819 |
| | Platelet FcgammaRIIA binds and internalizes IgG-containing complexes | Q79259022 |
| | Donor platelets stored for at least 3 days can elicit activation marker expression by the recipient's blood mononuclear cells: an in vitro study | Q79710832 |
| | Patient and product factors affecting platelet transfusion results | Q80521938 |
| | Platelets are covercytes, not phagocytes: uptake of bacteria involves channels of the open canalicular system | Q81638473 |
| | Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand | Q82705714 |
| | Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients | Q82709221 |
| | Why human platelets fail to kill bacteria | Q83347743 |
| | Altered release of regulated upon activation, normal T-cell expressed and secreted protein from human, normal platelets: contribution of distinct HIV-1MN gp41 peptides | Q84347898 |
| | Normal ranges of angiogenesis regulatory proteins in human platelets | Q84469561 |
| | CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia | Q85598285 |
| | Heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages | Q86615926 |
| | How can non-nucleated platelets be so smart? | Q87114360 |
| | Platelet immunology in fungal infections | Q88207878 |
| | Activated platelets rapidly up-regulate CD40L expression and can effectively mature and activate autologous ex vivo differentiated DC | Q95824300 |
| | CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 |
| | Granule exocytosis is required for platelet spreading: differential sorting of α-granules expressing VAMP-7 | Q24322893 |
| | Platelets amplify inflammation in arthritis via collagen-dependent microparticle production | Q24627618 |
| | Platelet Interaction with Innate Immune Cells | Q26745910 |
| | Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility | Q26784256 |
| | The signaling role of CD40 ligand in platelet biology and in platelet component transfusion | Q26863134 |
| | Transfusion as an Inflammation Hit: Knowns and Unknowns | Q28074933 |
| | Are Platelets Cells? And if Yes, are They Immune Cells? | Q28083403 |
| | A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia | Q28285557 |
| | Effect of storage time of platelet products on clinical outcomes after transfusion: a systematic review and meta-analyses. | Q30235391 |
| | Atomic description of the immune complex involved in heparin-induced thrombocytopenia | Q30665349 |
| | Very low platelet counts in post-transfusion purpura falsely diagnosed as heparin-induced thrombocytopenia. Report of four cases and review of literature. | Q33335366 |
| | Temporal aspects of heparin-induced thrombocytopenia | Q33337021 |
| | Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients | Q33364823 |
| | Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia | Q33392361 |
| | A patient with 'spontaneous' heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement | Q33392813 |
| | Transfusion of blood and blood products: indications and complications. | Q33394512 |
| | Association of natural anti-platelet factor 4/heparin antibodies with periodontal disease | Q33395715 |
| | Human platelets efficiently kill IgG-opsonized E. coli | Q33399755 |
| | The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia | Q33400714 |
| | Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes | Q33403085 |
| | Adrenal haemorrhage due to heparin-induced thrombocytopenia | Q33405730 |
| | Platelet transfusions for critically ill patients with thrombocytopenia | Q33412094 |
| | Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder | Q33414277 |
| | Me or not me? The danger of spontaneity | Q33415755 |
| | Spontaneous heparin-induced thrombocytopenia syndrome without any proximate heparin exposure, infection, or inflammatory condition: Atypical clinical features with heparin-dependent platelet activating antibodies | Q33418630 |
| | Platelets and infection - an emerging role of platelets in viral infection | Q33419642 |
| | A randomized noninferiority crossover trial of corrected count increments and bleeding in thrombocytopenic hematology patients receiving 2- to 5- versus 6- or 7-day-stored platelets | Q33420765 |
| | Nouvelle cuisine: platelets served with inflammation | Q33423427 |
| | Soluble Mediators in Platelet Concentrates Modulate Dendritic Cell Inflammatory Responses in an Experimental Model of Transfusion | Q33424060 |
| | Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria | Q33424826 |
| | Escherichia coli induces platelet aggregation in an FcγRIIa-dependent manner | Q33428410 |
| | Biophysical tools to assess the interaction of PF4 with polyanions | Q33435521 |
| | Platelets and immunity: From physiology to pathology | Q33441671 |
| | Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity | Q33442026 |
| | Biosynthesis of major platelet proteins in human blood platelets. | Q33457156 |
| | Effects of storage time on quantitative and qualitative platelet function after transfusion | Q33495049 |
| | Platelet dense granules: structure, function and implications for haemostasis. | Q33686166 |
| | The platelet as an immune cell-CD40 ligand and transfusion immunomodulation | Q33937074 |
| | Novel anti-bacterial activities of β-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. | Q34079154 |
| | Antimicrobial peptides from human platelets | Q34258124 |
| | Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum | Q34316582 |
| | Transfusion Medicine | Q34545148 |
| | Adverse events related to blood transfusion | Q34659761 |
| | Platelets and infections - complex interactions with bacteria. | Q35124418 |
| | Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury | Q35849153 |
| | Interactions between coagulation and complement--their role in inflammation | Q36022738 |
| | Platelets present antigen in the context of MHC class I. | Q36084093 |
| | The age of red blood cells is associated with bacterial infections in critically ill trauma patients | Q36159951 |
| | The emerging role of platelets in adaptive immunity | Q36379961 |
| | The storage lesions: From past to future. | Q36414235 |
| | Cytotoxic T Cells Use Mechanical Force to Potentiate Target Cell Killing | Q36730697 |
| | Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release. | Q36974434 |
| | Platelet alpha-granules: basic biology and clinical correlates | Q37487079 |
| | The role of CD40 and CD154/CD40L in dendritic cells | Q37518524 |
| | Is platelet transfusion associated with hospital-acquired infections in critically ill patients? | Q37566550 |
| | Platelet-bacterial interactions. | Q37678953 |
| | Platelet CD40L at the interface of adaptive immunity | Q37809369 |
| | Platelets and the immune continuum | Q37857647 |
| | Platelets and cytokines: How and why? | Q38017397 |
| | Platelets: active players in the pathogenesis of arthritis and SLE. | Q38032475 |
| | Platelets: production, morphology and ultrastructure | Q38037394 |
| | Platelets: bridging hemostasis, inflammation, and immunity | Q38099418 |
| | Bench-to-bedside review: Platelets and active immune functions - new clues for immunopathology? | Q38133641 |
| | Proteome changes in platelets after pathogen inactivation--an interlaboratory consensus | Q38200776 |
| | Platelets: at the nexus of antimicrobial defence | Q38211899 |
| | Blood product transfusions and reactions | Q38233708 |
| | Adverse effects of transfusion | Q38287593 |
| | Transfusion of platelets, but not of red blood cells, is independently associated with nosocomial infections in the critically ill. | Q38437038 |
| | Platelet refractoriness--practical approaches and ongoing dilemmas in patient management. | Q38551094 |
| | Platelet secretory behaviour: as diverse as the granules … or not? | Q38590568 |
| | Autoimmune heparin-induced thrombocytopenia | Q38605630 |
| | Transfusion-related acute lung injury: transfusion, platelets and biological response modifiers | Q38725992 |
| | Platelet Physiology | Q38754872 |
| | Platelet-mediated modulation of adaptive immunity | Q38996125 |
| | Amplification of bacteria-induced platelet activation is triggered by FcγRIIA, integrin αIIbβ3, and platelet factor 4. | Q39675280 |
| | Adverse Reactions to Transfusion of Blood Products and Best Practices for Prevention. | Q40106230 |
| | Duration of platelet storage and outcomes of critically ill patients. | Q40290880 |
| | Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3. | Q40736860 |
| | Internalization of IgG-coated targets results in activation and secretion of soluble CD40 ligand and RANTES by human platelets | Q42706493 |
| | Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion | Q43662394 |
| | Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion. | Q44519891 |
| | Impact of the duration of platelet storage in critically ill trauma patients | Q44843625 |
| | Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery 'spontaneous' HIT. | Q46195645 |
| | Comprehensive metabolomic study of platelets reveals the expression of discrete metabolic phenotypes during storage. | Q46248984 |
| | Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of 'spontaneous' HIT? | Q46567152 |
| | Amotosalen/UVA pathogen inactivation technology reduces platelet activability, induces apoptosis and accelerates clearance | Q47134888 |
| | Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments | Q47749276 |
| | Platelet-macrophage partnership in innate immunity and inflammation | Q47980827 |
| | Platelets kill bacteria by bridging innate and adaptive immunity via PF4 and FcγRIIA. | Q49922542 |
| | [Platelet transfusion and immunization anti-Rh1: implication for immunoprophylaxis]. | Q50459078 |
| | Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study. | Q50550381 |
| | Storage age of transfused platelets and outcomes after cardiac surgery. | Q50573944 |
| | Highly active antiretroviral therapy alters inflammation linked to platelet cytokines in HIV-1-infected patients. | Q50916673 |
| | Metabolites in stored platelets associated with platelet recoveries and survivals. | Q52870647 |
| | The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. | Q52962713 |
| | Rapid onset heparin-induced thrombocytopenia (HIT) without history of heparin exposure: a new case of so-called 'spontaneous' HIT. | Q53178725 |
| | Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. | Q53873685 |
| P304 | page(s) | 42 | |
| P577 | publication date | 2018-02-27 | |
| P1433 | published in | Frontiers in Medicine | Q27726181 |
| P1476 | title | The Non-Hemostatic Aspects of Transfused Platelets. | |
| P478 | volume | 5 | |